Product Description
HYPONIDD is used for the treatment of Polycystic Ovarian Syndrome (PCOS) on account of its role as an herbal insulin sensitiser with d-chiro-inositol edge. PCOS affects 6-10 % of women population and it is very often associated with insulin resistance. PCOS leads to amenorrhoea, anovulation, oligomenorrhoea, hirsutism, acne, etc. HYPONIDD in PCOS improves ovulatory function and several metabolic derangements associated with insulin resistance. HYPONIDD decreases the insulin resistance and thereby corrects the three axes namely metabolic, reproductive and steroidogenic. Haridra (Curcuma longa) has antiandrogenic, hypolipidemic, antiobesity and antioxidant properties. Gudmar (Gymnema sylvestre), Amalaki (Emblica officinalis), Guduchi (Tinospora cordifolia), Mamejoa (Enicostemma littorale) and Tarwar (Cassia auriculata) possess antidiabetic, hypolipidemic, cardioprotective and antioxidant properties. Thus, HYPONIDD is safe and effective insulin sensitising, antiandrogenic, antihyperglycemic, hypolipidemic and antioxidant formulation for the management of PCOS.

Use Under Medical Supervision